Newsmax White House correspondent Emerald Robinson went viral on Twitter with a claim that the CEO of Pfizer, Albert Bourla, has not been vaccinated against coronavirus.
Robinson linked to an article from the Jerusalem Post reporting that Bourla had to cancel a visit to Israel because he had not been fully vaccinated. The article was published on March 7, 2021, and notes that Bourla had received his first dose but not the second at the time. Bourla said in December 2020 that he would not “cut in line” to receive the vaccine early simply because of his status as the head of Pfizer, and instead would wait until he was eligible based on his age group. Axios reported on March 7 that Bourla said in an interview that he felt “liberated” after recently getting the first dose of his company’s vaccine. On March 10, Bourla tweeted a picture of himself receiving his second dose of the vaccine.
When asked about Robinson’s tweet, Steven Danehy, director of media relations at Pfizer, told The Dispatch Fact Check: “That is categorically false. Dr. Bourla has been fully vaccinated with the Pfizer-BioNTech vaccine.”
Per CDC guidelines, you’re not considered fully vaccinated until two weeks after you receive the second dose of the Pfizer vaccine.
Robinson noted several hours after her initial tweet that “The CEO of Pfizer announced on social media that he got his second vaccination shot on March 10,” but still gave no clarification that the canceled trip to Israel was to have occurred in March. When this fact check was published, the misleading tweet had 8,400 retweets and nearly 13,000 likes. The follow-up tweet had approximately 200 and 680, respectively.
The Dispatch Fact Check contacted Robinson and Newsmax for comment but neither responded.
If you have a claim you would like to see us fact check, please send us an email at factcheck@thedispatch.com. If you would like to suggest a correction to this piece or any other Dispatch article, please email corrections@thedispatch.com.
Please note that we at The Dispatch hold ourselves, our work, and our commenters to a higher standard than other places on the internet. We welcome comments that foster genuine debate or discussion—including comments critical of us or our work—but responses that include ad hominem attacks on fellow Dispatch members or are intended to stoke fear and anger may be moderated.
You are currently using a limited time guest pass and do not have access to commenting. Consider subscribing to join the conversation.
With your membership, you only have the ability to comment on The Morning Dispatch articles. Consider upgrading to join the conversation everywhere.